Katsuiku Hirokawa
Director/Board Member at Institute For Health &Life Science
Profile
Katsuiku Hirokawa is currently the Representative Director at the Institute For Health & Life Science since 2006.
Prior to this, he worked as an Independent Outside Director at tella, Inc.
Katsuiku Hirokawa active positions
| Companies | Position | Start |
|---|---|---|
| Institute For Health &Life Science | Director/Board Member | 2006-04-30 |
Former positions of Katsuiku Hirokawa
| Companies | Position | End |
|---|---|---|
| TELLA, INC. | Director/Board Member | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
| Institute For Health &Life Science |
- Stock Market
- Insiders
- Katsuiku Hirokawa
